Joshua Honghan Hou MD
Cataract Related, Cornea & External Disease, Refractive Surgery
Associate professor
Join to View Full Profile
420 Delaware St. SE, MMC 493University of MinnesotaMinneapolis, MN 55455
Phone+1 612-626-1442
Fax+1 612-626-7882
Dr. Hou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Cornea, External Diseases, and Refractive Surgery, 2013 - 2014- University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2010 - 2013
MedStart Georgetown University HospitalInternship, Transitional Year, 2009 - 2010
Washington University in St. Louis School of MedicineClass of 2009
Certifications & Licensure
MN State Medical License 2014 - 2025
IL State Medical License 2010 - 2014
DC State Medical License 2009 - 2010
VA State Medical License 2009 - 2010
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Decellularized Descemet Membrane Anterior Keratoplasty With Allogeneic Simple Limbal Epithelial Transplantation for Partial Limbal Stem Cell Deficiency Following Parti...Albert Y Cheung, Cameron B Reinisch, Joshua H Hou
Cornea. 2025-01-01 - Clinical Outcomes of Infectious Keratitis Associated with Contact Lens Wear Following Penetrating Keratoplasty: A Case Series.Angela A Cao, Dylan Stevens, Victoria Miller, Vania Rashidi, Joshua H Hou
International Ophthalmology. 2024-11-10 - Topical Tacrolimus Compared With Oral Tacrolimus for Postoperative Immunosuppression in Primary Keratolimbal Allograft.Tu M Tran, Tayaba N Azher, Corey J Miller, Joshua H Hou
Cornea. 2024-03-01
Press Mentions
From Head to Toe, 5 Ways We're Aging Better Than EverOctober 8th, 2019
Grant Support
- Ocular surface applications of Descemet's membraneUNIVERSITY OF MINNESOTA2022–2027
- K08NEI/ NIH2022–2027
Other Languages
- Chinese (Mandarin)
Industry Relationships
- Chief Scientific Officer, Brightstar Therapeutics, Inc.
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
